RxSight Inc (RXST)

NASD · Healthcare · Medical Devices · USA

RxSight Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.

RxSight Inc is a medical technology company that develops and commercializes the RxSight Light Adjustable Lens system for cataract surgery patients. The system comprises a photosensitive intraocular lens and a light delivery device that allows surgeons to customize and adjust vision after implantation. The company primarily serves ophthalmologists performing cataract procedures in the United States.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the RxSight Inc stock.

Our verdict on RXST

Slightly undervalued: intrinsic value $5.99 per share, market price $4.83, margin of safety 19.4% (as of 2026-11-17).

Its liquidation floor, current assets minus every liability, values the shares at $5.99; the price of $4.83 is 19% below that value.

ETFs with the most weight in RXST

17 more funds hold it; the full list is part of the paid plan.

More on RXST

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than RXST in Medical Devices

7 more in this industry show a wider margin of safety.

Is RXST undervalued or overvalued?

RXST is slightly undervalued (as of the 2026-11-17 close). Its liquidation floor, current assets minus every liability, values the shares at $5.99; the price of $4.83 is 19% below that value.

What is the intrinsic value of RXST?

$5.99 per share (as of the 2026-11-17 close), against a market price of $4.83. That is a margin of safety of 19.4%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.